Icrucumab ELISA Kit
Product Specifications
Background
Icrucumab (IMC-18F1), a human monoclonal antibody against vascular endothelial growth factor receptor-1 (VEGFR-1), potently inhibits ligand-dependent phosphorylation of VEGFR-1 and downstream signaling, making icrucumab an attractive candidate for antitumor activity.
Specifications
Icrucumab
Product Name Alternative
18F1, IMC-18F1, LY3012212, CAS: 1024603-92-6
Detection Method
Colorimetric
Assay Type
Quantitative
Sample Type
Plasma, Serum
Detection Range
0.31-5 μg/mL
Recovery
80-120%
Sensitivity
0.156 μg/ml
Shipping Conditions
2-8 °C
Storage Conditions
The stability of ELISA kit is determined by the loss rate of activity. The loss rate of this kit is less than 10% prior to the expiration date under appropriate storage condition.
Notes
For Research Use Only.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC471655-500 1x 500 µL
NKX2.2 (Neuroendocrine & Ewing's Sarcoma Marker), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
LY421659 100 µg
SLC38A8 (NM_001080442) Human Over-expression Lysate
Sign In for Pricing
View Details 
BNC741855-100 1x 100 µL
TTF-1 / NKX2.1 (Thyroid & Lung Epithelial Marker) (NX2.1/1855R), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details